About M.K. Proteins
M.K. Proteins is a publicly listed company based in Ambala (India) founded in 2012. Developer of pure markers, herbal concentrates, and nutraceutical products. The company has 50 employees. Its Indian entity M K Proteins Limited reported revenue of ₹383 Cr. M.K. Proteins offers products and services including Refined Vegetable Oils and Oil Refining Services. Its focus areas include Food and Agriculture and Food Processing.
Company details
M.K. Proteins, established in 2012, excels in food and agriculture, and food processing. . Committed to advancing standards, it focuses on innovation and efficiency. It continues to evolve, meeting industry challenges with strategic approaches and commitment to quality.
- Headquarters Ambala, India
- Employees 50
- Stage Public
- SectorsConsumer
- Website mkproteins.in
- Legal Name M K Proteins Limited
- Market Cap₹148 Cr
MKPL · NSE
- Share Price₹3.95
0.00% today
- Revenue₹383 Cr
FY 2025-26 · +43.0% YoY
- EBITDA₹11.42 Cr
Margin 3.0%
- Net Profit₹6.83 Cr
FY 2025-26 · -15.6% YoY
- P/E (TTM)31.6x
P/B 1.9x
- Employee Count50
Associated legal entities of M.K. Proteins
M.K. Proteins operates through M K Proteins Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| M K Proteins Limited Listed CIN L15500HR2012PLC046239 | Active | 15 Jun 2012 | Ambala, Haryana | ₹383 Cr | 48 | 10 | View details |
Products & Services of M.K. Proteins
M.K. Proteins offers a comprehensive portfolio of products and services, including Refined Vegetable Oils and Oil Refining Services.
Vegetable refined oils are produced for various uses in food and related applications
Refining processes for oils such as rice bran and sunflower are offered as part of operations
Board of directors of M K Proteins Limited (M.K. Proteins)
M K Proteins Limited is the primary company behind M.K. Proteins. The board of M K Proteins Limited currently have 8 directors; the longest-serving is Parvind Kumar, appointed in 2012. 11 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Parvind Kumar DIN 00126933 | Director | 15 Jun 2012 | 14 yrs 4 mo | M K Proteins Limited |
| Raj Kumar DIN 00126983 | Director | 15 Jun 2012 | 14 yrs 4 mo | M K Proteins Limited |
| Vinod Kumar DIN 00150507 | Whole-time director | 10 Dec 2016 | 9 yrs 11 mo | M K Proteins Limited |
| Parmod Kumar DIN 00126965 | Managing Director | 15 Feb 2017 | 9 yrs 8 mo | M K Proteins Limited |
| Tej Mohan Singh DIN 10130417 | Director | 05 May 2023 | 3 yrs 6 mo | M K Proteins Limited |
| Shipra Jain DIN 10130874 | Director | 05 May 2023 | 3 yrs 6 mo | M K Proteins Limited |
| Deepak Khetarpal DIN 00732804 | Director | 23 Aug 2025 | 1 yr 2 mo | M K Proteins Limited |
| Aritika Garg DIN 11895058 | Director | 22 Aug 2026 | 2 mo | M K Proteins Limited |
IPO & Listings of M.K. Proteins
M.K. Proteins is a publicly listed company on the NSE with ticker symbol MKPL in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date13 Jun 2023
- Listed onNSE: MKPL
- Listed entityM K Proteins Limited
- Exchange sectorProcess industries
- ISININE964W01021
- Share price₹3.96 (+0.76% on the day) · 2026-10-14
- Market capitalisation₹149 Cr
- Price to earnings31.6
- EPS (diluted, trailing year)₹0.13
- Volume (last session)201,717
Financials of M.K. Proteins
Exchange-reported figures of M K Proteins Limited, the listed company behind M.K. Proteins (NSE: MKPL).
Financial Highlights
FY 2025-26 · StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 383 | 268 | 246 | 315 | 256 | 311 | 194 |
| Revenue growth | +43.0% | +9.0% | -22.0% | +23.1% | -17.8% | +60.3% | - |
| EBITDA | 11.42 | 12.50 | 16.64 | 17.15 | 15.72 | 16.00 | 4.81 |
| EBITDA margin | +3.0% | +4.7% | +6.8% | +5.5% | +6.1% | +5.1% | +2.5% |
| Profit before tax | 9.39 | 11.47 | 15.46 | 14.98 | 14.06 | 14.32 | 2.43 |
| Net profit | 6.83 | 8.09 | 11.17 | 10.91 | 10.16 | 10.36 | 1.77 |
| Net profit margin | +1.8% | +3.0% | +4.6% | +3.5% | +4.0% | +3.3% | +0.9% |
| EPS (₹) | 0.18 | 0.22 | 0.30 | 8.74 | 24.42 | 24.91 | 4.36 |
| Balance sheet | |||||||
| Total assets | 114 | 109 | 81.39 | 95.59 | 76.47 | 54.52 | 49.56 |
| Net worth | 76.30 | 69.47 | 61.08 | 49.86 | 39.60 | 29.34 | 18.95 |
| Total debt | 37.14 | 38.72 | 20.08 | 45.53 | 36.78 | 25.13 | 30.57 |
| Cash & bank | 0.44 | 0.03 | 0.09 | 0.06 | 0.01 | 0.00 | 0.11 |
| Net working capital | 101 | 96.45 | 70.98 | 90.96 | 72.64 | 51.36 | 45.83 |
| Cash flow | |||||||
| Cash from operations | 5.43 | (16.13) | 32.42 | (5.87) | (10.12) | 5.54 | (4.47) |
| Cash from investing | (1.60) | (1.48) | (5.88) | 0.01 | (1.53) | (0.21) | 0.18 |
| Cash from financing | (3.43) | 17.55 | (26.51) | 5.92 | 11.66 | (5.44) | 4.40 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 115 | 146 | 89.56 | 32.43 | 115 | 137 | 39.48 | 33.69 |
| Revenue growth (YoY) | +0.2% | +6.4% | +126.9% | -3.7% | +100.5% | - | - | - |
| Other income | 0.00 | 0.12 | 0.02 | 0.12 | 0.00 | 0.02 | 0.25 | 0.21 |
| Total expenses | 113 | 143 | 87.19 | 31.39 | 109 | 133 | 37.68 | 31.45 |
| EBITDA | 2.51 | 2.50 | 2.37 | 1.04 | 5.51 | 4.65 | 1.80 | 2.24 |
| EBITDA margin | +2.2% | +1.7% | +2.6% | +3.2% | +4.8% | +3.4% | +4.6% | +6.6% |
| Depreciation | 0.15 | 0.11 | 0.12 | 0.11 | 0.10 | 0.09 | 0.11 | 0.07 |
| Interest | 0.52 | 0.79 | 0.30 | 0.06 | 0.70 | 0.67 | 0.07 | 0.03 |
| Profit before tax | 1.84 | 1.72 | 1.97 | 0.99 | 4.71 | 3.91 | 1.87 | 2.35 |
| Tax | 0.47 | 0.58 | 0.53 | 0.25 | 1.19 | 1.12 | 0.48 | 0.59 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 115 | 146 | 89.56 | 32.43 | 115 | 137 | 39.48 | 33.69 |
| Revenue growth (YoY) | +0.2% | +6.4% | +126.9% | -3.7% | +100.5% | - | - | - |
| Other income | 0.00 | 0.12 | 0.02 | 0.12 | 0.00 | 0.02 | 0.25 | 0.21 |
| Total expenses | 113 | 143 | 87.19 | 31.39 | 109 | 133 | 37.68 | 31.45 |
| EBITDA | 2.51 | 2.50 | 2.37 | 1.04 | 5.51 | 4.65 | 1.80 | 2.24 |
| EBITDA margin | +2.2% | +1.7% | +2.6% | +3.2% | +4.8% | +3.4% | +4.6% | +6.6% |
| Depreciation | 0.15 | 0.11 | 0.12 | 0.11 | 0.10 | 0.09 | 0.11 | 0.07 |
| Interest | 0.52 | 0.79 | 0.30 | 0.06 | 0.70 | 0.67 | 0.07 | 0.03 |
| Profit before tax | 1.84 | 1.72 | 1.97 | 0.99 | 4.71 | 3.91 | 1.87 | 2.35 |
| Tax | 0.47 | 0.58 | 0.53 | 0.25 | 1.19 | 1.12 | 0.48 | 0.59 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 383 | 268 | 246 | 315 | 256 | 311 | 194 |
| Revenue growth | +43.0% | +9.0% | -22.0% | +23.1% | -17.8% | +60.3% | - |
| Other income | 0.26 | 0.48 | 0.45 | 0.55 | 0.14 | 0.05 | 0.31 |
| Total expenses | 371 | 255 | 229 | 298 | 240 | 295 | 189 |
| Employee cost | 0.00 | 1.79 | 1.83 | 1.49 | 1.70 | 1.43 | 1.44 |
| EBITDA | 11.42 | 12.50 | 16.64 | 17.15 | 15.72 | 16.00 | 4.81 |
| EBITDA margin | +3.0% | +4.7% | +6.8% | +5.5% | +6.1% | +5.1% | +2.5% |
| Depreciation | 0.44 | 0.35 | 0.53 | 0.82 | 0.91 | 0.91 | 1.17 |
| Interest | 1.85 | 1.16 | 1.10 | 1.90 | 0.89 | 0.82 | 1.52 |
| Profit before tax | 9.39 | 11.47 | 15.46 | 14.98 | 14.06 | 14.32 | 2.43 |
| Tax | 2.56 | 3.06 | 4.26 | 4.06 | 3.86 | 3.93 | 0.63 |
| Net profit | 6.83 | 8.09 | 11.17 | 10.91 | 10.16 | 10.36 | 1.77 |
| Net profit margin | +1.8% | +3.0% | +4.6% | +3.5% | +4.0% | +3.3% | +0.9% |
| EPS (₹) | 0.18 | 0.22 | 0.30 | 8.74 | 24.42 | 24.91 | 4.36 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 37.54 | 37.54 | 37.54 | 12.51 | 4.17 | 4.17 | 4.17 |
| Reserves & surplus | 38.76 | 31.93 | 23.54 | 37.35 | 35.43 | 25.17 | 14.78 |
| Shareholders' funds (net worth) | 76.30 | 69.47 | 61.08 | 49.86 | 39.60 | 29.34 | 18.95 |
| Secured loans | 36.19 | 37.75 | 19.09 | 44.52 | 36.78 | 25.13 | 26.61 |
| Unsecured loans | 0.95 | 0.97 | 0.99 | 1.01 | 0.00 | 0.00 | 3.96 |
| Total debt | 37.14 | 38.72 | 20.08 | 45.53 | 36.78 | 25.13 | 30.57 |
| Total liabilities | 114 | 109 | 81.39 | 95.59 | 76.47 | 54.52 | 49.56 |
| Assets | |||||||
| Gross block | 14.13 | 13.39 | 12.48 | 12.41 | 11.47 | 9.90 | 3.10 |
| Net block | 4.73 | 3.68 | 2.77 | 3.29 | 3.11 | 2.46 | 3.10 |
| Capital work in progress | 7.10 | 6.66 | 5.90 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 110 | 111 | 79.27 | 71.20 | 49.77 | 37.70 | 38.99 |
| Sundry debtors | 2.11 | 1.40 | 3.57 | 16.06 | 29.21 | 20.65 | 9.50 |
| Cash & bank balances | 0.44 | 0.03 | 0.09 | 0.06 | 0.01 | 0.00 | 0.11 |
| Loans & advances | 5.90 | 5.76 | 2.90 | 11.26 | 3.33 | 5.84 | 4.23 |
| Total current assets | 118 | 119 | 85.83 | 98.58 | 82.32 | 64.19 | 52.83 |
| Total current liabilities | 17.38 | 22.06 | 14.85 | 7.62 | 9.68 | 12.83 | 7.00 |
| Net working capital | 101 | 96.45 | 70.98 | 90.96 | 72.64 | 51.36 | 45.83 |
| Total assets | 114 | 109 | 81.39 | 95.59 | 76.47 | 54.52 | 49.56 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.03 | 0.09 | 0.06 | 0.01 | 0.00 | 0.11 | 0.00 |
| Net cash from operating activities | 5.43 | (16.13) | 32.42 | (5.87) | (10.12) | 5.54 | (4.47) |
| Net cash from investing activities | (1.60) | (1.48) | (5.88) | 0.01 | (1.53) | (0.21) | 0.18 |
| Net cash from financing activities | (3.43) | 17.55 | (26.51) | 5.92 | 11.66 | (5.44) | 4.40 |
| Net change in cash | 0.40 | (0.06) | 0.03 | 0.06 | 0.01 | (0.11) | 0.11 |
| Closing cash | 0.44 | 0.03 | 0.09 | 0.06 | 0.01 | 0.00 | 0.11 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +43.0% | +9.0% | -22.0% | +23.1% | -17.8% | +60.3% | - |
| EBITDA growth | -8.6% | -24.9% | -3.0% | +9.1% | -1.8% | +232.6% | - |
| PBT growth | -18.1% | -25.8% | +3.2% | +6.5% | -1.8% | +489.3% | +6.1% |
| Net income growth | -15.6% | -27.6% | +2.4% | +7.4% | -1.9% | +485.3% | - |
| Revenue CAGR (3Y) | +6.7% | +1.5% | -7.6% | +17.5% | +18.1% | +22.2% | +5.8% |
| EBITDA CAGR (3Y) | -12.7% | -7.4% | +1.3% | +52.8% | +46.7% | +42.2% | -0.9% |
| Profitability & leverage | |||||||
| Net income margin | +1.8% | +3.1% | +4.6% | +3.5% | +4.0% | +3.3% | +0.9% |
| Return on capital employed | - | +13.3% | +18.7% | +19.6% | +22.8% | +29.1% | +8.6% |
| Return on net worth | - | +12.9% | +20.2% | +24.4% | +29.5% | +43.0% | +10.1% |
| Debt / equity | - | 0.45 | 0.59 | 0.92 | 0.90 | 1.15 | 1.57 |
| Long-term debt / equity | - | 0.02 | 0.04 | 0.07 | 0.10 | 0.17 | 0.15 |
| Interest cover | 16.85 | 9.55 | 6.83 | 11.64 | 6.01 | 5.43 | 41.76 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 20.55 | 19.73 | 26.37 | 23.95 | 47.86 | 29.15 |
| Inventory turnover | - | 2.81 | 3.26 | 5.21 | 5.85 | 8.11 | 5.68 |
| Debtors turnover | - | 107.73 | 25.02 | 13.91 | 10.26 | 20.64 | 19.08 |
| EPS (₹) | 0.18 | 0.22 | 0.30 | 8.74 | 24.42 | 24.91 | 4.36 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 1.85 | 1.63 | 39.85 | 94.95 | 70.34 | 45.43 |
Web traffic of M.K. Proteins
The website of M.K. Proteins (mkproteins.in) receives about 2.2K visits a month.
- Monthly visits2.2K
▲ 0.9% vs previous month
Top companies in Food Processing
2 companies that operate in the same segment as M.K. Proteins (Food Processing) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Fruits and vegetables processing services are provided by Sahyadri Farms. | 2011 | Nashik, Maharashtra, India | USD 84.86 M | USD 115.08 M | 2,299 | |
Brand of beverage products | 1995 | Gurugram, Haryana, India | USD 133 M | USD 2.33 B | 12,570 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about M.K. Proteins
Complete news archive for M.K. Proteins
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about M.K. Proteins
M.K. Proteins was founded in 2012.
M.K. Proteins is headquartered in Ambala, India. It is registered at Ambala, Haryana, India.
M.K. Proteins has 50 employees.
The primary company behind M.K. Proteins, M K Proteins Limited, reported revenue of ₹383 Cr for FY 2026, up 43% year on year.
M.K. Proteins, established in 2012, excels in food and agriculture, and food processing. . Committed to advancing standards, it focuses on innovation and efficiency. It continues to evolve, meeting industry challenges with strategic approaches and commitment to quality.
M.K. Proteins offers Refined Vegetable Oils and Oil Refining Services.
Yes, M.K. Proteins is publicly traded on NSE under the ticker symbol MKPL.
M.K. Proteins operates through M K Proteins Limited.
The legal entities of M.K. Proteins currently have 9 directors, including Parvind Kumar, Neha Agarwal, Raj Kumar and others.